No actionable change — market sales data does not affect clinical protocols or patient care decisions.
Steady market normalization signals a healthy dispensing environment and may guide clinic capacity planning, hiring, and inventory decisions for practice owners.
- 01U.S. hearing aid unit sales showed strong year-over-year growth in Q3 2023.
- 02Both private/commercial and VA market segments contributed to growth.
- 03Sales trends reflect continued post-pandemic market normalization.
- 04Q4 2023 is estimated to continue the positive trajectory (~7.3% overall growth shown in chart).
- 05The pandemic quarter Q2 2020 saw a severe -58.6% drop, with recovery accelerating from 2021 onward.
Q3 2023 hearing aid sales were strong and markets continued to normalize post-pandemic.
unknownpartially supportedQ3 2023 estimated overall growth was approximately 9.3% year-over-year.
unknownpartially supported